India plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a govern...

People are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying coun...

Biocon partners with Medix to distribute Liraglutide for chronic weight management in Mexico, offering affordable obesity treatment options...

Doctors say patients come with specific queries regarding weight-loss drugs, which have become both the first preference and the last resor...

Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in gen...

Eli Lilly has commenced phase three clinical trials in India for a new oral weight-loss drug called orforglipron. The trials aim to assess ...

New data suggests that semaglutide may also cut the risk of stroke or heart attack, and may delay the progression of kidney disease in diab...

Novo Nordisk, a Danish pharmaceutical company renowned for its diabetes medicines, is now positioning itself as the world's leading weight-...

Fake weight loss injections, falsely marketed as Ozempic or Saxenda, have triggered significant safety alarms in the United Kingdom. Author...

Counterfeit injection pens falsely labeled as Ozempic, a popular diabetes drug also used for weight loss, have been discovered in Europe, a...

The Danish pharmaceutical company Novo Nordisk has introduced its weight-loss drug Wegovy to the United Kingdom. This strategic expansion i...